Related Experiment Video
Updated: Feb 17, 2026

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
Published on: March 20, 2017
Bariatric surgery versus conservative management for morbidly obese patients in Spain: a cost-effectiveness analysis
Raquel Sanchez-Santos1, Esther Mariño Padin2, Daniel Adam3
1a General and Digestive Surgery Department , Complejo Hospitalario de Pontevedra, Instituto de Investigación Galicia Sur , Pontevedra , Spain.
Background:
We assessed the cost-effectiveness of bariatric surgery (BS) versus conservative management (CM) for treating morbid obesity in Spain.
Methods:
We developed a probabilistic Markov model to estimate health outcomes, quality-adjusted life years (QALY), life years gained (LYG), and costs over lifetime and 10-year horizons. Combined common BS procedures were compared with CM. Clinical and utility inputs were obtained from the literature and resource use and costs from local sources (€2017).
Results:
Over the 10-year horizon, BS led to a cost increment of €9,386 and 1.6 additional QALY (€5,966/QALY). Leading to 0.6 LYG and 4.4 QALY gains and €300/patient average cost savings over lifetime, BS could potentially significantly reduce diabetes and cardiovascular disease risk over the considered horizons. Despite short-term cost reductions, surgery delay may lead to significant clinical benefits loss.
Conclusions:
Compared to CM, BS is a more effective and less costly alternative for treating morbid obesity in Spain.
Related Concept Videos
Drug Dosing: Obese Patients
Obesity
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

